Market Access Growth Stratevi has a strong focus on health economics, outcomes research, pricing and market access, with recent expansions into medical affairs and dedicated access communications. This presents opportunities to upsell integrated value dossiers, publication support, and strategic planning services to pharma and biotech manufacturers seeking broader access initiatives.

New Leadership Adds Scope Recent hires and leadership appointments, including Senior Principal, Market Access and a medical affairs lead, indicate an expanding capability to support field medical, market access storytelling, and cross-functional launches. Target companies launching new therapies that require payer-ready narratives and access strategies.

Software & Workflow Launch of StrateFlow and project management tools signals an emphasis on efficiency and stakeholder alignment. Market to firms needing streamlined HEOR workflows, real-world evidence programs, and faster delivery of value dossiers through integrated software-assisted services.

Expanded Service Lines Recent service diversification into medical affairs and access communications, plus historic offerings in ICER reviews, economic models, and real-world studies, creates cross-sell opportunities for pharmaceutical clients seeking end-to-end support from evidence generation to market access communication.

Sizing Opportunity With estimated annual revenue in the mid-range and a boutique team size, Stratevi can target mid-to-large biotech and specialty pharma organizations looking for specialized HEOR and access storytelling capacity, offering scalable engagement models for value dossiers, publications, and stakeholder education.